Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.12
Delayed Data
As of 3:36pm ET
 0.00 / 0.00%
Today’s Change
0.73
Today|||52-Week Range
1.66
+13.24%
Year-to-Date
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close1.12
Today’s open1.12
Day’s range1.07 - 1.12
Volume96,001
Average volume (3 months)189,775
Market cap$48.6M
Dividend yield--
Data as of 3:36pm ET, 03/04/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-241.48%
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-19.03%
P/E ratio1.8
Price/Sales1.47
Price/Book9.23

Competitors

 Today’s
change
Today’s
% change
ORMPOramed Pharmaceutica...+0.03+0.69%
ONTXOnconova Therapeutic...+0.02+0.89%
HEBHemispherx Biopharma...+0.01+4.91%
OGXIOncoGenex Pharmaceut...+0.05+1.92%
Data as of 3:52pm ET, 03/04/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$34.5M
Annual profit (last year)$18.2M
Net profit margin52.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, COO &
Secretary
George W. Hebard
Chief Financial Officer &
Vice President-Finance
Richard L. Feinstein
Corporate headquarters
Piscataway, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account